An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
Crossref DOI link: https://doi.org/10.1186/s13601-017-0172-9
Published Online: 2017-10-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Riedl, Marc A.
Bernstein, Jonathan A.
Craig, Timothy
Banerji, Aleena
Magerl, Markus
Cicardi, Marco
Longhurst, Hilary J.
Shennak, Mustafa M.
Yang, William H.
Schranz, Jennifer
Baptista, Jovanna
Busse, Paula J.
Funding for this research was provided by:
Shire HGT
